NCT05079074View on ClinicalTrials.gov

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer

CompletedOBSERVATIONAL
Enrollment

223

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2021

Conditions
Metastatic Breast CancerCirculating Tumor DNAGene Abnormality
Interventions
DIAGNOSTIC_TEST

ctDNA testing

ctDNA testing was performed for late-stage metastatic breast cancer patients to trace their ctDNA abnormality.

All Listed Sponsors
lead

Hunan Cancer Hospital

OTHER

NCT05079074 - Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer | Biotech Hunter | Biotech Hunter